Advanced Medical Solutions Group (LON:AMS) Price Target Increased to GBX 300 by Analysts at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS) had its price objective upped by Berenberg Bank from GBX 290 ($3.66) to GBX 300 ($3.79) in a research report report published on Wednesday morning, MarketBeat reports. Berenberg Bank currently has a buy rating on the stock.

Advanced Medical Solutions Group Price Performance

AMS traded up GBX 5.60 ($0.07) during trading on Wednesday, reaching GBX 195.60 ($2.47). The company’s stock had a trading volume of 580,135 shares, compared to its average volume of 409,193. The company has a quick ratio of 4.58, a current ratio of 5.67 and a debt-to-equity ratio of 3.74. The firm has a fifty day simple moving average of GBX 205.42 and a two-hundred day simple moving average of GBX 202.15. Advanced Medical Solutions Group has a 1 year low of GBX 165.60 ($2.09) and a 1 year high of GBX 261 ($3.30). The company has a market cap of £425.10 million, a price-to-earnings ratio of 2,796.80, a PEG ratio of 5.00 and a beta of 0.58.

Advanced Medical Solutions Group Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, June 21st. Investors of record on Thursday, May 30th will be issued a GBX 1.66 ($0.02) dividend. This represents a yield of 0.79%. The ex-dividend date of this dividend is Thursday, May 30th. This is an increase from Advanced Medical Solutions Group’s previous dividend of $0.70. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is 2,857.14%.

Insider Activity at Advanced Medical Solutions Group

In related news, insider Eddie Johnson bought 27,051 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was purchased at an average price of GBX 192 ($2.43) per share, for a total transaction of £51,937.92 ($65,636.19). 2.70% of the stock is owned by insiders.

Advanced Medical Solutions Group Company Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.